Saranadasa M and Wang ES. Vascular endothelial growth factor inhibition: conflicting roles in tumor growth. Cytokine, August 12 online (in press), 2010.
Kantarjian HM, Giles F, Greenberg PL, Paquette RL, Wang ES, Gabrilove JL, Garcia-Manero G, Hu K, Franklin JL, Berger DP. Safety and Efficacy of Romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacytidine therapy. Blood, Jul 14 online (in press), 2010.
Wang ES, Sait SNJ, Gold D, Mashtare T, Starostik P, Ford LA, Wetzler M, Nowak NJ, Deeb G. Genomic, immunophenotypic, and FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia followed by aberrant karyotype AML at relapse. Cancer Genet Cytogenetics, 202(2):101-7, 2010.
Lal D, Park JA, Demock K, Marinaro J, Perez AM, Lin MH, Tian L, Mashtare TJ, Murphy M, Prey J, Wetzler M, Fetterly GJ, Wang ES. Aflibercept exerts anti-vascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models. Molec Cancer Therapeutics, 9(10): 2737-51, 2010.
Noor S, Tan W, Wilding G, Ford LA, Barcos M, Sait SNJ, Block A, Thompson J, Wang ES, Wetzler M. Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 112 Cases. Leukemia Research, August 18 online (in press) 2010.
Lee HJ, Thompson JE, Wang ES, Wetzler M. Philadelphia chromosome-positive acute lymphoblastic leukemia: Current treatment and future perspectives. Cancer, in press 2010.
Brady MT, Lee J, Ferrone S, Wang ES, Wetzler M. Interferon-secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells. Leukemia Research in press, 2010.
Deeb G, Vaughan MM, McInnis I, Ford LA, Sait SN, Starostik P, Wetzler M, Mashtare T, Wang ES. Hypoxia-inducible factor-1alpha (HIF-1alpha) protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia patients. Leuk Research in press 2010.